GSK (GSK) announced that the European Medicines Agency, EMA, has granted Priority Medicines, PRIME, Designation for GSK5764227, its ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

Shares of GSK PLC GSK inched up 0.22% to £13.43 Friday, on what proved to be an all-around positive trading session for the ...

GSK said on Friday the addition of its cancer drug Jemperli to both standard of care chemotherapy and Zejula maintenance ...

Teva Pharmaceutical Industries Ltd. ADR 1.14% $25.35B ...

Revised deal with Zhifei to manage near-term challenges GSK shares marginally lower Potential RSV collaboration for initial 10-year term Dec 5 (Reuters) - China's Zhifei (300122.SZ), opens new tab ...

O novo presidente da GSK no Brasil, Patrick Eckert, recebe a princesa Astrid da Bélgica em visita à sede da empresa no Rio. Destaque para a parceria de 40 anos com o programa brasileiro de ...

LONDON — A blood cancer treatment from GSK helped patients live longer in a pivotal trial, a significant finding as the once-withdrawn drug mounts a comeback. In the study, a treatment ...

GSK has terminated a phase 1/2 hepatitis B trial after the therapeutic vaccine regimen failed to meet the efficacy endpoint, denting the company’s hopes of creating a functional cure for the ...

Cambridge-based AstraZeneca and London-based GSK (formerly GlaxoSmithKline) are the two flagships of the British drug manufacturing industry. For several years, GSK was the leading pharmaceutical ...

Days after Merck & Co. posted a disappointing result on patient survival from its PD-1/PARP combination of Keytruda and Lynparza in ovarian cancer, GSK delivered a similar message for its Jemperli ...

GSK has made another trip to China to build out its antibody-drug conjugate (ADC) pipeline, returning with an option on a preclinical Duality Biologics candidate that could ultimately cost the Big ...